Navigation Links
EU Recognizes Importance of ASI's Research on Developing New Smart Imaging Molecular Tools for Combating Neurodegenerative Diseases
Date:2/16/2010

MIGDAL HAEMEK, Israel, Feb. 16 /PRNewswire/ -- Neurodegenerative diseases such as Alzheimer's set a challenge for modern medicine, as their origins are unclear and the comprehension of the progression of symptoms often relies upon a patients' behavior.

Applied Spectral Imaging (ASI) a leading provider of comprehensive imaging solutions for Pathology and Cytogenetics, was chosen by the European Union (EU) to be one out of nine industry and academia groups to form the Lupas consortium. ASI possess unique spectral technology that labels each region of the image with multiple colors beyond the basic red, green and blue colors that are available today in digital cameras.

LUPAS seeks to develop new smart imaging molecular tools for combating neurodegenerative diseases. Via modern imaging technology, development and validation of novel, properly functionalized, luminescent conjugated polymers (LCPs) can give rise to entirely new and innovative methodology that can be used for biomedical research, diagnosis, monitoring and prognosis, and for support and guidance of therapeutic interventions for Alzheimer's disease and prior diseases. ASI harnesses its unique capabilities within "Lupas" to help identify and characterize amyloids that form the accumulation of plaques and proteins in the brain, usually associated with Alzheimer patients.

The consortium is composed of expert groups in experimental optics, polymer synthesis, magnetic resonance imaging (MRI), and synthesis of functionalized magnetic nanoparticles, amyloid structure, AD mouse models, clinical AD and prior diseases. This project establishes strategic links between mainly SME based Industries, expert researchers at universities and principal users in terms of hospitals. The project consortium will develop and share an efficient plan for dissemination and exploitation of the project results.

Limor Siphosh, CEO of ASI, " We hope that by the end of the third year, we will have a better understanding of Alzheimer's disease, 'mad cow disease' and others. Knowledge will bring recognition and in time the ability to accurately diagnose and treat these diseases."  

About ASI

Applied Spectral Imaging (ASI), is a leading developer and manufacturer of comprehensive solutions for Pathology and Cytogenetics imaging, computer aided technology and data management needs. ASI was founded in 1993; it is a privately held company with two fully owned subsidiaries that manage sales and customer support in North America and Europe, along with independent distributors throughout the rest of the world. The company owns more than 25 patents in the US alone, and other patents in Europe and Japan.  These patents cover general use spectral imaging, image analysis, scanning techniques, spectroscopy in life science and medicine and patents for specific applications.

For further information: www.spectral-imaging.com

Media Contact: IDAN Communications;

Keren Wulich: +972-9-9514666 or keren@idancom.com

SOURCE Applied Spectral Imaging (ASI)

RELATED LINKS
http://www.spectral-imaging.com

'/>"/>

SOURCE Applied Spectral Imaging (ASI)
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
2. Science Magazine Recognizes Monsanto as Top Employer
3. National Academy of Sciences Recognizes Monsantos Chief Technology Officer for Development of Agricultural Biotechnology
4. FactPoint Group Recognizes Halogen for "On-Choice" Deployment Model
5. New Study Recognizes Halogen Customer for Best Practices in Employee Performance and Talent Management
6. American Urological Association (AUA) Clinical Guidelines Recognizes Cryotherapy as Treatment Option for Prostate Cancer Patients
7. The NCIIA Recognizes Collegiate Biomedical Engineering Innovations
8. Frost & Sullivan Recognizes Kionixs Dominance in the MEMS Accelerometers Market Through Product Line Strategy
9. Clontech Laboratories, Inc. Recognizes the 2008 Winners of the Nobel Prize in Chemistry
10. Collegiate Inventors Competition(R) Recognizes Top Student Inventors
11. Cleveland Clinic Recognizes Circulating Tumor Cell Technology as Top Medical Innovation for 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , ... June 23, 2016 , ... ... release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering ... retention in this eBook by providing practical tips, tools, and strategies for clinical ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
Breaking Biology Technology:
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting ... are setting a new clinical standard in telehealth thanks ... By leveraging the higi platform, IMPOWER patients can routinely ... pulse and body mass index, and, when they opt ... and convenient visit to a local retail location at ...
(Date:3/29/2016)... 2016 LegacyXChange, Inc. (OTC: ... SelectaDNA/CSI Protect are pleased to announce our successful effort ... variety of writing instruments, ensuring athletes signatures against counterfeiting ... from athletes on LegacyXChange will be assured of ongoing ... Bill Bollander , CEO states, "By ...
(Date:3/22/2016)... and SANDY, Utah , March ... operates the highest sample volume laboratory in ... and UNIConnect, leaders in clinical sequencing informatics and molecular ... of a project to establish the informatics infrastructure for ... NSO has been contracted by the Ontario Ministry ...
Breaking Biology News(10 mins):